Equities

Limes Schlosskliniken AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Limes Schlosskliniken AG

Actions
  • Price (EUR)500.00
  • Today's Change0.00 / 0.00%
  • Shares traded91.00
  • 1 Year change+61.29%
  • Beta0.9414
Data delayed at least 15 minutes, as of Mar 05 2026 13:22 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Limes Schlosskliniken AG is a Germany-based company. The Company engages in the Operation of clinics and healthcare facilities. This includes the provision of management and administrative services for other companies, in particular clinic operating companies, as well as businesses that directly serve and promote this company purpose.

  • Revenue in EUR (TTM)42.54m
  • Net income in EUR4.60m
  • Incorporated2015
  • Employees237.00
More ▼

Institutional shareholders

7.59%Per cent of shares held by top holders
HolderShares% Held
Chelverton Asset Management Ltd.as of 30 Jun 20259.19k3.06%
Lupus alpha Asset Management AGas of 30 Jun 20256.10k2.03%
Barius Capital Management GmbHas of 28 Jun 20243.05k1.02%
HANSAINVEST Hanseatische Investment-GmbHas of 31 Aug 20251.53k0.51%
Universal-Investment-Gesellschaft mbH (Invt Mgmt)as of 30 Nov 20241.36k0.45%
Paladin Asset Management Investmentaktiengesellschaft TGVas of 31 Dec 20241.13k0.38%
Philippe Hottinguer & Cie Gestion SASas of 30 Jun 2025410.000.14%
Lazard Asset Management LLCas of 31 Jan 202613.000.00%
More ▼
Data from 28 Jun 2024 - 31 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.